• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR 0.00% 6.1¢

NYRADA INC.

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR 22/08/24 1 437
22/08/24 Last post  Bendunstan Comments Created with Sketch.  1  Views Created with Sketch.  437 
NYR 22/08/24 0 168
22/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  168 
NYR 22/08/24 0 127
22/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  127 
NYR 22/08/24 0 177
22/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  177 
NYR 22/08/24 3 1.0K
22/08/24 Last post  Bendunstan Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
NYR 19/08/24 35 9.1K
19/08/24 Last post  Bendunstan Comments Created with Sketch.  35  Views Created with Sketch.  9.1K 
NYR 16/08/24 3 881
16/08/24 Last post  Bendunstan Comments Created with Sketch.  3  Views Created with Sketch.  881 
NYR 09/08/24 194 70K
09/08/24 Last post  Sweetmole Comments Created with Sketch.  194  Views Created with Sketch.  70K 

See All Discussions arrow Created with Sketch.

Timeline

Full Year Results FY2024
22 Aug 18:25
 
Annual Report for year ended 30 June 2024
22 Aug 18:20
 
Appendix 4G and Corporate Governance Statement
22 Aug 18:15
 
Preliminary final report
22 Aug 18:15
 
Brain Injury Program GLP Studies Further Update No 3
20 Aug 08:04
 
Investor Presentation
15 Aug 08:16
 
View More arrow Created with Sketch.
(20min delay)
Last
6.1¢
Change
0.000(0.00%)
Mkt cap ! $11.11M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 68566 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 9630 2
View Market Depth
Last trade - 10.06am 26/08/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.